Trial intelligence / Profile preview

Ulinastatin for Advanced Lung Cancer Resection via Thoracotomy

ChiCTR-IPR-16008078Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jun 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of ulinastatin in bronchial carcinoma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: postoperative pulmonary complications, hospital mortality and 2 more. Started Jun 2015; status: recruiting.

02

Drugs

ulinastatin
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR-IPR-16008078.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-16008078.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call